Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients

Completed · Not applicable

Conditions studied: Cancer-related Problem/Condition, Ambulatory Care

In brief

The purpose of this study is to see if Glad Press 'n Seal works as a moisture barrier for central line that is left in place during ambulatory oncology clinical care.

Key facts

Study ID

NCT01967836

Run by

Maureen T Greene

People needed

11

Starts

2013-10-01

Expected to finish

2015-04-01

Last updated by the study team

2017-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects requiring mediport or peripherally inserted central venous catheter line access for 3-5 days
• Able to read and write English
• Use showering as a means of home hygiene

You may not qualify if…

• Subjects with eczema/psoriasis at the line insertion area
• Subjects with active line/site irritation/infection
• Subjects on chemotherapy protocols including anti-epidermal growth factor receptor drugs (cetuximab, panitumumab) or ipilimumab as there is a high incidence of skin rash as a side effect of these medications
• Patients who do not intend to shower as a means of home hygiene

Where it is running

• Rieman Cancer Center — Milwaukee, Wisconsin, United States
• Wheaton Franciscan Healthcare-St Joseph campus — Milwaukee, Wisconsin, United States
• WFH-St. Francis — Milwaukee, Wisconsin, United States
• Wheaton Franciscan - Wauwatosa Campus — Wauwatosa, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.